Colin Goudelocke, MD
Education and Research
Postgraduate Training
Fellowship
Medical University of South Carolina
Charleston, South Carolina
Female Urology, Bladder and Pelvic Health
July 2009 - July 2010
Residency
Louisiana State University Health Sciences Center
Shreveport, Louisiana
July 2005 - July 2009
Internship
Louisiana State University Health Sciences Center
Shreveport, Louisiana
July 2004 - July 2005
Faculty Appointments
January 2024 - Present
Director
Pelvic Health Center of Excellence
Ochsner Health System
New Orleans, Louisiana
June 2023 - Present
Senior Physician
Department of Urology
Ochsner Health System
New Orleans, Louisiana
June 2019 - June 2023
Physician
Department of Urology
Ochsner Health System
New Orleans, Louisiana
June 2015 - June 2019
Clinical Assistant Professor
Department of Urology
University of Tennessee - Chattanooga
Chattanooga, Tennessee
July 2010 - August 2011
Assistant Professor
Department of Urology
Medical University of South Carolina
Charleston, South Carolina
Education
M.D.
Louisiana State University School of Medicine
New Orleans, Louisiana
August 2000 - June 2004
B.S
Louisiana State University
Baton Rouge, Louisiana
August 1997 - December 1999
Washington and Lee University
Lexington, Virginia
August 1995 - August 1997
Board Certification
General Urology
Certified by the American Board of Urology
Female Pelvic Medicine and Reconstructive Surgery
Sub-specialty certified by the American Board of Urology
Clinical Trials
2022-2025
Avation (Principal Investigator)
A prospective sham-controlled safety and efficacy study of a smar, self-adjusting surgery-free wearable bladder modulation and digital health system with objective confirmation of nerve activation for use in the home by subjects with overactive bladder syndrome, REDUCEOAB Study
2022-2023
Uromedica (Principal Investigator)
A Clinical Investigation of the Adjustable Continence Therapy (ACT) for Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency, UM08
2022-2023
Medtronic (Principal Investigator)
Pelvic electrically evoked recording (PEER 2) Sacral Neuromodulation Study
2022-2024
Medtronic (CEC Chair)
TITAN 2 Pivotal Study
2021-2023
Urovant (Principal Investigator)
Phase IV Clinical Study of Gemtesa (vibegron) in Overactive Bladder, ComposurURO-901-4001
2020-2023
Avation (Principal Investigator)
FREEOAB Pilot Study AMHOAB2001
2020-2024
Medtronic (Principal Investigator)
Evaluation of InterStim Micro System Performance and Safety (ELITE) to Confirm Long-Term Outcomes - Post Market Clinical Follow-Up Study ELITE Study NCT04506866
2020-2021
Medtronic (Principal Investigator)
Pelvic electrically evoked recording (PEER) Sacral Neuromodulation Study
2019-2020
Medtronic (Principal Investigator)
An Investigation of Tolerability of Novel Signal Frequency in Sacral Neuromodulation, Sacral Neuromodulation Trial Phase II Study
2018-2020
Medtronic (Principal Investigator)
An Investigation of Cyclical Randomly Varying Amplitude in Sacral Neuromodulation, Sacral Neuromodulation Trial Phase Study MDT17031
2020-2021
Medtronic (Principal Investigator)
Pelvic electrically evoked recording (PEER) Sacral Neuromodulation Study
2019-2020
Medtronic (Principal Investigator)
An Investigation of Tolerability of Novel Signal Frequency in Sacral Neuromodulation, Sacral Neuromodulation Trial Phase II Study
2018-2019
Medtronic (Principal Investigator)
An Investigation of Cyclical Randomly Varying Amplitude in Sacral Neuromodulation, Sacral Neuromodulation Trial Phase Study MDT17031
2017-2019
Medtronic (Principal Investigator)
InterStim® Amplitude Study NCT03335761
2016-2018
Astellas (Principal Investigator)
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB) OAB PILLAR 178-MA-1005
Abstracts and Presentations
Goudelocke, C. Xavier, K. Pecha,B. Burgess, K. Perrouin-Verbe, M. Krlin,R. Michaels, J. Shah, S. Peyronnet, B. Zaslau, S. Noel, K. Gillespie,E. Elterman,D. Nitti, V. Clinical performance and safety of sacral neuromodulation at 24 months in subjects with overactive bladder: Results from the global post-market ELITE study
Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, February 20-23, 2024
Sahai, A. Goudelocke, C. Lavin, V. Peyronnet, B. Elterman, D. Perrouin-Verbe, M. Shah, S. Bukkapatnam, R. Xavier, K. Smits, M. Noel, K. Wu, M. Malde, S. Rechargeable sacral neuromodulation device improves symptoms of non-obstructive urinary retention at 6-month follow-up in a global, prospective, post-market study
Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, February 20-23, 2024
Goudelocke, C. Dhir, R. Cline, K. Poulos, D. Shapiro, E. A prospective, sham-conrolled safety and efficacy trial of a wearable transcutaneous tibial neuromodulation system treating overactive bladder syndrome (REDUCE OAB)
Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, February 20-23, 2024
Goudelocke C. Ruiz, H. Linder, B. Villegas, G. Shah K. Slopsema, J. Bittner, K. Li X. Carlson, N. Jungbauer-Nikolas, L. Investigating a new threshold for SNM: sensing sacral evoked responses from the lead
Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, February 20-23, 2024
Major, N. Goudelocke, C. Efficacy of stress incontinence surgery in managing “stand-up urgency” in overactive bladder patients
Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, February 20-23, 2024
Perrouin-Verbe, M, Goudelocke, C, Xavier, K, Pecha, B, MD, Burgess, K, MD, Krlin, R, Michaels, J, Shah, S, Peyronnet, B, Zaslau, S, Papi, B, Bittner, K. Elterman,D, Nitti, V. Device programming of the rechargeable InterStim Micro sacral neuromodulation device through 12 months in a global post-market study
European Urology Association Annual Meeting March 2023
Goudelocke, C, Xavier, K. Pecha, B. MD, Burgess, K. MD, Perrouin-Verbe, M. Krlin, R. Michaels, J. Shah, S. Peyronnet, B. Zaslau, S. Papi, B. Gilespie, E. Elterman,D. Nitti, V. InterStimTM Micro Improves Quality of Life in Overactive Bladder Subjects at 12-Month Follow Up in the Global Post-Market ELITE Study
Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, March 7-11, 2023
Major, N, Nguyen, C, Goudelocke, C. Pelvic health navigation for overactive bladder: Is automation the way forward?
Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, March 7-11, 2023
Colin Goudelocke, Victoria Lavin, Marie-Aimée Perrouin-Verbe, Dean Elterman, Benoît Peyronnet, Martijn Smits, Sagar Shah, Keith Xavier, Ryan Krlin, Raviender Bukkapatnam, Bianca Papi, Emily Gillespie, Arun Sahai, Sachin Malde. InterStimTM Micro improves symptoms and patient-reported outcomes in subjects with non-obstructive urinary retention at 3-month follow-up
International Continence Society Annual Meeting, September 28, 2023
Goudelocke C. Ruiz, H. Linder, B. Villegas, G. Shah K. Slopsema, J. Bittner, K. Li X. Carlson, N. Jungbauer-Nikolas, L. Sensing in Sacral Neuromodulation: Sacral Evoked Responses as Objective, Patient-specific Measures of Stimulation Programs
International Continence Society Annual Meeting, September 28, 2023
International Continence Society Annual Meeting, September 28, 2023Goudelocke, C, Xavier, K, Pecha, B, MD, Burgess, K , Perrouin-Verbe, M, Krlin, R, Elterman,D, Nitti, V. Evaluation of clinical performance and safety for the rechargeable Interstim Micro in overactive bladder subjects: 6-month results from the global post-marker (ELITE) study
· American Urogynecologic Society Annual Meeting May 2022
Xavier, K, Goudelocke, C, Pecha, B, MD, Burgess, K, MD, Perrouin-Verbe, M, Krlin, R, Michaels, J, Shah, S, Peyronnet, B, Zaslau, S, Papi, B, Elterman,D, Nitti, V. Evaluation of clinical performance and safety for the rechargeable Interstim Micro in overactive bladder subjects: 3-month results from the global post-marker (ELITE) study
· American Urological Association Annual Meeting MAY 2022
Ryan, A, Hill, H, Goudelocke, C. The use of D-mannose in the prevention of recurrent urinary tract infections.
· Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, February 2022
Goudelocke, C, Slopsema, J, Bittner, K, Jungbauer, L, Mayoette, M, Miller, A, Stolen, K, Offutt, S, Zirpel, L. Sensing Sacral Signals: Pelvic electrically evoked recording (PEER) feasibility study findings.
· Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, February 2022
Goudelocke, C, Xavier, K, Pecha, B, MD, Burgess, K, MD, Perrouin-Verbe, M, Krlin, R, Michaels, J, Shah, S, Peyronnet, B, Zaslau, S, Papi, B, Elterman,D, Nitti, V. Interstim Micro Improves quality of life in overactive bladder subjects at 3-month follow up in a global, prospective, post-market study.
· Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, February 2022
Holtel, M, Couvaras, A, Goudelocke, C. Does use of a low-dose non-depolarzing neuromuscular blocker affect opening motor thresholds for sacral neuromodulation?
· Southeastern Section of the American Urologic Association March 2022
· Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, February 2022
Blake, Z, Couvaras, A, Goudelocke, C. A simple anchor technique prevents migration of sacral neuromodulation test leads.
· Southeastern Section of the American Urologic Association March 2022
· Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, February 2022
Williams, J, Goudelocke, C. Optimal timing for second stage sacral neuromodulation
· Southeastern Section of the American Urologic Association March 2022
Elterman,D, Goudelocke, C, Xavier, K, Pecha, B, Burgess, K, Perrouin-Verbe, M, Krlin, R, Michaels, J, Shah, S, Peyronnet, B, Zaslau, S, Grunow, N, Bittner, K, Nitti, V. Evaluation of Rechargeable InterStim Micro System Performance and Safety: 3-month results from the OAB cohort of the ELITE study.
· European Urology Association Annual Meeting March 2022
Hill, H, Goudelocke, C. A Novel Sacral Neuromodulation Infection Protocol is Associated with Reduction in Device Infection [Update].
· American College of Surgeons Quality and Safety Conference July 12, 2021
· Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, February 2020
Elterman, D, Goudelocke, C, Ehlert, M, de Ridder, D, McCrery, R, Pakzad, M, Kaufman, M, Shah, S, Margolis, E, Bukkapatnam, R, Johnson, G, Brink, T, Champs, M. A prospective multicenter, international study to explore the effect of three different amplitude setting in subjects with urgency incontinence receiving Interstim therapy
· Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, February 2020
Elterman,D, Goudelocke, C, Xavier, K, Pecha, B, Burgess, K, Perrouin-Verbe, M, Krlin, R, Michaels, J, Shah, S, Peyronnet, B, Zaslau, S, Grunow, N, Bittner, K, Nitti, V. Evaluation of Rechargeable InterStim Micro System Performance and Safety: 3-month results from the OAB cohort of the ELITE study.
· European Urology Association Annual Meeting March 2022
Goudelocke, C, Jahn, H. A sacral neuromodulation sensory response stabilizes early after implantation.
· Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, February 2020
Goudelocke, C, Gurtner, K, Couvaras, A. The relationship between motor and sensory responses in sacral neuromodulation.
· Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, February 2020
Goudelocke, C, Gurtner, K, Couvaras, A, Long, A. A “mixed” motor sacral neuromodulation lead placement results in higher implant rates.
· Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, February 2020
Conner,J, Long,A, Goudelocke, C. A novel sacral neuromodulation infection protocol is associated with reduction in device infection.
· Southeastern Section of AUA, March 2018
· Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, February 2018
Conner,J, Long,A, Goudelocke, C. Optimized Sacral Neuromodulation lead placement is feasible and does not increase operative times.
· Southeastern Section of AUA, March 2018
· Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, March, February 2018
Singh A, Hunt S, Wheelock A, Galen N, Goudelocke C, Class J. Outcomes of robotic-assisted ureteroneocystostomy in the management of gynecological surgery associated ureteric complications.
· World Congress of Endourology, October 2013
Singh A, Hunt S, Wheelock A, Galen N, Goudelocke C, Class J. Outcomes of robotic-assisted ureteroneocystostomy in the management of gynecological surgery associated ureteric complications.
· World Congress of Endourology, October 2013
Singh A, Hunt S, Wheelock A, Galen N, Goudelocke C, Class J. Open and robotic nephron sparing surgery for T1a or greater renal cell carcinoma: a single center experience.
· World Congress of Endourology, October 2013
Singh A, Hunt S, Wheelock A, Galen N, Goudelocke C, Class J. A comparison of robotic and open radical cystectomy for urothelial carcinoma in octogenarians.
· World Congress of Endourology, October 2013
Goudelocke C, McIntyre M, Nickles W, Rovner E. Effects of estrogen treatment on mesh-augmented vaginal prolapse repair
· Society for Urodynamics and Female Urology, Fellows Forum. February 25, 2010
· AUA Annual Meeting, San Francisco, CA. May 28, 2010
Goudelocke C, Rovner E. Trans-vaginal bladder neck closure with posterior urethral flap
· Society for Urodynamics and Female Urology, St. Petersburg, FL. February 26, 2010
· AUA Annual Meeting, San Francisco, CA. May 28, 2010
Goudelocke C, Williams BJ, Kubricht WS, Gomelsky A. Determinants of failure after sling surgery for female stress urinary incontinence.
· Southeastern Section of the AUA, Mobile, AL. March 26, 2009
· Louisiana State Urological Society, Shreveport, LA. April 18, 2009
· AUA Annual Meeting, Chicago, IL. April 28, 2009
· ICS Annual Meeting, San Francisco, CA. September 30, 2009
Haverkorn M, Goudelocke C, Williams BJ, Kubricht WS, Gomelsky A. Is obesity truly a risk factor for failure in sling surgery for stress incontinence in women?
· Society for Urodynamics and Female Urology, Miami, FL. March 1, 2008
· Southeastern Section of the AUA, San Diego, CA. March 9, 2008
· AUA Annual Meeting, Orlando, FL. May 19, 2008
Goudelocke C, Haverkorn R, Williams BJ, Gomelsky A. Risk factors for persistent or recurrent stress urinary incontinence after transobturator slings.
· Louisiana State Urological Society, New Orleans, LA. April 20, 2008
· Southeastern Section of the AUA, San Diego, CA. March 8, 2008
Goudelocke C, Ankem M. Bilateral laparoscopic retroperitoneal adrenalectomy in the prone position.
25th World Congress of Endourology and SWL. Cancun, Mexico. October 2007 (Video)
Park S, Goudelocke C, Cadeddu J, Shingleton B. Evaluation of ureteropelvic junction injury after intentional ablation injury.
· Southeastern Section of the AUA, Orlando, FL. March 8, 2007.
Goudelocke C, Haverkorn R, Williams BJ, Tareen B, Bologna R, Gomelsky A. Commercial prolapse repair “kits” vs. traditional transvaginal prolapse repairs: A comparison of efficacy and cost.
· Society for Urodynamics and Female Urology, San Diego, CA. February 23, 2007
· Southeastern Section of the AUA, Orlando, FL. March 10, 2007
· Ohio Urologic Society, Columbus, OH. March 17, 2007.
· Louisiana State Urological Society, Lafayette, LA. April 15, 2007.
· AUA Annual Meeting, Anaheim, CA. May 22, 2007.
Goudelocke C, Figueroa J. Measuring the effects of Azaftig on adipocyte lipolysis.
Louisiana State University Medical Center Summer Research Forum, New Orleans, LA. August 25, 2001.
Peer-Reviewed Publications
Goudelocke, C. Sobol, J. Poulos, D. Enemchukwu, E. Zaslau, S. Dhir, R. A Multicenter Study Evaluating the FREquency of Use and Efficacy of a Novel Closed-Loop Wearable Tibial Neuromodulation System for Overactive Bladder and Urgency Urinary Incontinence (FREEOAB). Urology 183, P63-69, January 2024
Goudelocke, C, Jungbauer-Nikolas, L., Bittner, K., Offutt, S., Miller, A., Slopsema, J. Sensing in Sacral Neuromodulation: A Feasibility Study in Subjects With Urinary Incontinence and Retention. Neuromodulation August 2023: 1–7.
Goudelocke, C., Hill, H., Major, N., Couvaras, A, Long, A. “A novel sacral neuromodulation protocol is associated with reduction in removal for device infection”. International Urogynecology Journal. October 2023.
Colin Goudelocke MD, Keith Xavier MD, Barry Pecha MD, Kimberly Burgess MD, Marie-A. Perrouin-Verbe MD, PhD, Ryan Krlin MD, Jodi Michaels MD, Sagar Shah MD, Benoît Peyronnet MD, PhD, Stanley Zaslau MD, MBA, Mylène Champs MS, Bianca Papi MS, Katie Bittner PhD, Dean Elterman MD, MSc, FRCSC, Victor Nitti MD. Evaluation of clinical performance and safety for the rechargeable InterStim Micro device in overactive bladder subjects: 6-month results from the global postmarket ELITE study. Neurourology and Urodynamics. 2023; 42: 761- 769.
Couvaras, Anastasia, Goudelocke, Colin. “Optimizing Lead Placement in Sacral Neuromodulation”. Current Bladder Dysfunction Reports: 16(74-79):2021
Elterman, D, Goudelocke, C, Ehlert, M, de Ridder, D, McCrery, R, Pakzad, M, Kaufman, M, Shah, S, Margolis, E, Bukkapatnam, R, Johnson, G, Brink, T, Champs, M. “A prospective multicenter, international study to explore the effect of three different amplitude setting in subjects with urgency incontinence receiving Interstim therapy”. Neurourology and Urodynamics: Volume 40, Issue 3, pages 920-928, March 1, 2021.
Ryan, Alixandra, Goudelocke, Colin. “Surgical Options for Post-Prostatectomy Incontinence: A Review”. Annals of Urology and Nephrology 2(2): 2020
Andrew Colhoun BS, Colin Goudelocke MD, Eric S. Rovner MD “Reproduction of Female Lower Urinary Tract Symptoms on Urodynamics” LUTS: Lower Urinary Tract Symptoms, Volume 4, Issue 2, pages 59-62, May 2012
Lebed B, Goudelocke C, Gilchist A, and Rovner E. “Trans-vaginal Bladder Neck Closure with Posterior Urethral Flap for the Devastated Urethra” Urology, 2011. 78(1):208-12.
Rovner E and Goudelocke C. “Management of pelvic organ prolapse”. Current Opinions in Urology, 2010. 20: 490-494.
Rovner E and Goudelocke C. “Urodynamics in the evaluation of overactive bladder”. Current Urology Reports,2010. Volume 11, Issue 5.
Rovner E and Goudelocke C. “Which injectable to use in the treatment of intrinsic sphincter deficiency”. Current Opinions in Urology, 2010. 20:296-301.
Rovner E and Goudelocke C. "Interstitial Cystitis." eMedicine. Medscape, 8 Nov. 2009 <http://emedicine.medscape.com/>.